Amino Terminal B-Type Natriuretic Peptide, Renal Function, and Prognosis in Acute Heart Failure: A Hospital Cohort Study

Journal of Cardiac Failure

Volumn 13, Issue 4, 2007, Pages 275-280

  Pimenta, Joana Martins ^a   Almeida, Rui ^b   Araújo, José Paulo ^a   Azevedo, Ana ^a   Friões, Fernando ^a   Rocha Gonçalves, Francisco ^b   Ferreira, António ^a   Bettencourt, Paulo ^a  

^a University of Porto   (Portugal)

^b HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

event free survival; heart decompensation; NT proBNP; renal failure

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CAPTOPRIL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; LISINOPRIL; SPIRONOLACTONE;

ACUTE HEART FAILURE; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PORTUGAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY; SURVIVAL ANALYSIS;

EID: 34248561798     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.01.001     Document Type: Article

References (25)

1. Berry C., Hogg K., Norrie J., Stevenson K., Brett M., and McMurray J. Heart failure with preserved left ventricular systolic function: a hospital cohort study. Heart 91 (2005) 907-913
2. McCullough P.A., Duc P., Omland T., McCord J., Nowak R.M., Hollander J.E., et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41 (2003) 571-579
3. Anwaruddin S., Lloyd-Jones D.M., Baggish A., Chen A., Krauser D., Tung R., et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement. Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47 (2006) 91-97
4. Meyer K.B., and Levey A.S. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task force on Cardiovascular Disease. J Am Soc Nephrol 9 (1998) S31-S42
5. Coresh J., Astor B., and Sarnak M. Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 13 (2004) 73-81
6. Weiner D.E., Tighiouart H., Amin M.G., Stark P.C., MacLeod B., Griffith J.L., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15 (2004) 1307-1315
7. McCullough P.A. Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med 3 (2002) 71-76
8. Zoccali C. Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention. Nephrol Dial Transplant 17 Suppl 11 (2002) 50-54
9. Schrier R.W. Role of diminished renal function in cardiovascular mortality. Marker or pathogenetic factor?. J Am Coll Cardiol 47 (2006) 1-8
10. Ishizaka Y., Yamamoto Y., Tanaka M., Kato F., Ishizaka Y., Yokota N., et al. Molecular forms of human brain natriuretic peptide (BNP) in plasma of patients on hemodialysis (HD). Clin Nephrol 43 (1995) 237-242
11. Haug C., Metzele A., Steffgen J., Kochs M., Hombach V., and Grunert A. Increased brain natriuretic peptide and atrial peptide plasma concentration in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Clin Invest 72 (1994) 430-434
12. Franz M., Woloszczuk W., and Hörl W.H. Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases. Kidney Int 59 (2001) 1928-1934
13. McCullough P.A., and Sandberg K.R. B-type natriuretic peptide and renal disease. Heart Fail Rev 8 (2003) 355-358
14. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
15. Bayes-Genis A., Lopez L., Zapico E., Cotes C., Santalo M., Ordonez-Llanos J., et al. NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality. J Card Fail 11 (2005) S3-S8
16. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 330 (1999) 877-884
17. Bettencourt P.M. Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives. Heart 91 (2005) 1489-1494
18. Cowie M.R., Jourdain P., Maisel A., Dahlstrom U., Follath F., Isnard R., et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24 (2003) 1710-1718
19. Silver M.A., Maisel A., Yancy C.W., McCullough P.A., Burnett Jr. J.C., Francis G.S., et al. BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 10 (2004) 1-30
20. Doust J.A., Pietrzak E., Dobson A., and Glasziou P.P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330 (2005) 625
21. McCullough P.A., and Sandberg K.R. Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med 4 Suppl 4 (2003) S13-S19
22. van Kimmenade R.R.J., Januzzi J.L., Baggish A.L., Lainchbury J.G., Bayes-Genis A., Richards M., et al. Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure. Redefining the cardiorenal interaction?. J Am Coll Cardiol 48 (2006) 1621-1627
23. Bettencourt P., Azevedo A., Pimenta J., Frioes F., Ferreira S., and Ferreira A. N-terminal pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004) 22168-22174
24. O'Brien R.J., Squire I.B., Demme B., Davies J.E., and Ng L.L. Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF. Eur J Heart Fail 5 (2003) 499-506
25. Hartmann F., Packer M., Coats A.J., Fowler M.B., Krum H., Mohacsi P., et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 110 (2004) 1780-1786